JP2025092589A5 - - Google Patents
Info
- Publication number
- JP2025092589A5 JP2025092589A5 JP2025053695A JP2025053695A JP2025092589A5 JP 2025092589 A5 JP2025092589 A5 JP 2025092589A5 JP 2025053695 A JP2025053695 A JP 2025053695A JP 2025053695 A JP2025053695 A JP 2025053695A JP 2025092589 A5 JP2025092589 A5 JP 2025092589A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- variable region
- chain variable
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020043021 | 2020-03-12 | ||
| JP2020043021 | 2020-03-12 | ||
| PCT/JP2021/009798 WO2021182573A1 (ja) | 2020-03-12 | 2021-03-11 | 癌の治療及び／又は予防のための医薬品 |
| JP2021532006A JP7797875B2 (ja) | 2020-03-12 | 2021-03-11 | 癌の治療及び／又は予防のための医薬品 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532006A Division JP7797875B2 (ja) | 2020-03-12 | 2021-03-11 | 癌の治療及び／又は予防のための医薬品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025092589A JP2025092589A (ja) | 2025-06-19 |
| JP2025092589A5 true JP2025092589A5 (enExample) | 2026-02-02 |
Family
ID=77671643
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532006A Active JP7797875B2 (ja) | 2020-03-12 | 2021-03-11 | 癌の治療及び／又は予防のための医薬品 |
| JP2025053695A Pending JP2025092589A (ja) | 2020-03-12 | 2025-03-27 | 癌の治療及び／又は予防のための医薬品 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532006A Active JP7797875B2 (ja) | 2020-03-12 | 2021-03-11 | 癌の治療及び／又は予防のための医薬品 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230129035A1 (enExample) |
| EP (1) | EP4119156A4 (enExample) |
| JP (2) | JP7797875B2 (enExample) |
| KR (1) | KR20220152318A (enExample) |
| BR (1) | BR112022018157A2 (enExample) |
| CA (1) | CA3175137A1 (enExample) |
| WO (1) | WO2021182573A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2502940T3 (es) * | 2008-08-05 | 2014-10-06 | Toray Industries, Inc. | Composición farmacéutica para el tratamiento y la prevención del cáncer |
| MX2024001104A (es) * | 2021-07-27 | 2024-02-23 | Toray Industries | Medicamento para el tratamiento y/o prevencion de cancer. |
| EP4378478A4 (en) * | 2021-07-27 | 2025-11-12 | Toray Industries | MEDICINE FOR THE TREATMENT AND/OR PREVENTION OF CANCER |
| CN117651566A (zh) * | 2021-07-27 | 2024-03-05 | 东丽株式会社 | 用于癌的治疗和/或预防的药品 |
| CN119768182A (zh) * | 2022-08-24 | 2025-04-04 | 东丽株式会社 | 用于癌的治疗和/或预防的药品 |
| EP4578458A1 (en) * | 2022-08-24 | 2025-07-02 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| WO2024043258A1 (ja) * | 2022-08-24 | 2024-02-29 | 東レ株式会社 | 癌の治療及び／又は予防のための医薬品 |
| KR20250170141A (ko) * | 2023-03-14 | 2025-12-04 | 다이이찌 산쿄 가부시키가이샤 | 항 cdh6 항체-약물 콘주게이트와 vegf 저해제의 조합 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| AU701342B2 (en) | 1994-07-13 | 1999-01-28 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human interleukin-8 |
| DK1069185T3 (da) | 1998-04-03 | 2011-06-27 | Chugai Pharmaceutical Co Ltd | Humaniseret antistof mod human vævsfaktor (TF) og fremgangsmåde til at konstruere humaniseret antistof |
| DE69942021D1 (de) | 1998-04-20 | 2010-04-01 | Glycart Biotechnology Ag | Glykosylierungs-engineering von antikörpern zur verbesserung der antikörperabhängigen zellvermittelten zytotoxizität |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| PT1914244E (pt) | 1999-04-09 | 2013-07-26 | Kyowa Hakko Kirin Co Ltd | Processo para regular a actividade de moléculas funcionais sob o ponto de vista imunológico |
| FR2807767B1 (fr) | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
| AU2004204494B2 (en) | 2003-01-09 | 2011-09-29 | Macrogenics, Inc. | Identification and engineering of antibodies with variant Fc regions and methods of using same |
| US8388955B2 (en) | 2003-03-03 | 2013-03-05 | Xencor, Inc. | Fc variants |
| DE10359795A1 (de) | 2003-12-19 | 2005-07-21 | Bayer Technology Services Gmbh | Strangverdampfervorrichtung |
| ES2502940T3 (es) | 2008-08-05 | 2014-10-06 | Toray Industries, Inc. | Composición farmacéutica para el tratamiento y la prevención del cáncer |
| CN102802661B (zh) | 2009-06-22 | 2016-01-13 | 米迪缪尼有限公司 | 用于位点特异性偶联的工程改造的Fc区 |
| MX2012003404A (es) | 2009-09-22 | 2012-09-12 | Volker Sandig | Procedimiento para producir moleculas que contienen estructuras de glicano especializadas. |
| JP5906739B2 (ja) | 2010-02-04 | 2016-04-20 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| PL2532680T3 (pl) | 2010-02-04 | 2015-10-30 | Toray Industries | Kompozycja medyczna do leczenia raka i/lub zapobiegania |
| PT2532367T (pt) * | 2010-02-04 | 2018-11-09 | Toray Industries | Agente farmacêutico para o tratamento e/ou prevenção do cancro |
| AU2011211698B2 (en) | 2010-02-04 | 2015-07-16 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| EP2532365B1 (en) * | 2010-02-04 | 2016-05-04 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
| JP5923985B2 (ja) | 2010-02-04 | 2016-05-25 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| EP3208281A1 (en) | 2010-03-29 | 2017-08-23 | Zymeworks, Inc. | Antibodies with enhanced or suppressed effector function |
| ES2609846T3 (es) | 2011-08-04 | 2017-04-24 | Toray Industries, Inc. | Composición farmacéutica para el tratamiento y/o prevención del cáncer pancreático |
| WO2013018883A1 (ja) | 2011-08-04 | 2013-02-07 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| JP6065591B2 (ja) | 2011-08-04 | 2017-01-25 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| BR112014002621B1 (pt) | 2011-08-04 | 2022-09-20 | Toray Industries, Inc | Anticorpo, ou seu fragmento, composição farmacêutica, uso de um anticorpo e uso de uma composição farmacêutica |
| EP2740796B1 (en) | 2011-08-04 | 2017-05-17 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| CN103717739B (zh) | 2011-08-04 | 2015-07-29 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
| HUE045461T2 (hu) | 2012-02-21 | 2019-12-30 | Toray Industries | Gyógyászati készítmény rák kezelésére |
| MX357505B (es) | 2012-02-21 | 2018-07-12 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. |
| CN104169303B (zh) | 2012-02-21 | 2018-05-29 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
| BR112014021099A2 (pt) | 2012-02-21 | 2020-12-01 | Toray Industries, Inc | anticorpo, composição farmacêutica, dna e método de tratamento e/ou prevenção de câncer e uso de um anticorpo |
| AU2013241036B2 (en) | 2012-03-30 | 2017-07-20 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of liver cancer |
| MX357965B (es) | 2012-03-30 | 2018-08-01 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion de cancer de vesicula biliar. |
| CN112587671A (zh) | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| MX360671B (es) * | 2013-08-09 | 2018-11-13 | Toray Industries | Composición farmacéutica para el tratamiento y/o prevención del cáncer. |
| AU2018287519B2 (en) * | 2017-06-22 | 2021-07-22 | Novartis Ag | IL-1beta binding antibodies for use in treating cancer |
| AU2019242520A1 (en) * | 2018-03-30 | 2020-10-29 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
| JP7103097B2 (ja) | 2018-09-13 | 2022-07-20 | トヨタ自動車株式会社 | 燃料電池車両 |
-
2021
- 2021-03-11 JP JP2021532006A patent/JP7797875B2/ja active Active
- 2021-03-11 WO PCT/JP2021/009798 patent/WO2021182573A1/ja not_active Ceased
- 2021-03-11 KR KR1020227035364A patent/KR20220152318A/ko active Pending
- 2021-03-11 BR BR112022018157A patent/BR112022018157A2/pt unknown
- 2021-03-11 EP EP21767020.7A patent/EP4119156A4/en active Pending
- 2021-03-11 CA CA3175137A patent/CA3175137A1/en active Pending
- 2021-03-11 US US17/910,538 patent/US20230129035A1/en active Pending
-
2025
- 2025-03-27 JP JP2025053695A patent/JP2025092589A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025092589A5 (enExample) | ||
| JP2020510422A5 (enExample) | ||
| US9994632B2 (en) | Humanized or affinity-matured anti Ang-2 antibody and uses thereof | |
| JP2019535250A5 (enExample) | ||
| JP2018508483A5 (enExample) | ||
| JP2017535257A5 (enExample) | ||
| JP2020514310A5 (enExample) | ||
| JP2013527762A5 (enExample) | ||
| JP2017514461A5 (enExample) | ||
| IL253462B (en) | Cancer treatment with monoclonal antibodies against latency-associated peptide | |
| JP2018503365A5 (enExample) | ||
| JP2014530215A5 (enExample) | ||
| JP2014158469A5 (enExample) | ||
| HRP20180262T1 (hr) | Monoklonska anti-gt468 protutijela za liječenje karcinoma | |
| CN112513094A (zh) | 结合人her2的抗体、其制备方法和用途 | |
| CA3208455A1 (en) | Novel anti-gremlin1 antibodies | |
| CN118871467A (zh) | 抗pd-l2抗体 | |
| JPWO2023008462A5 (enExample) | ||
| US20240309116A1 (en) | Antibodies against ror1 and uses thereof | |
| JPWO2020102387A5 (enExample) | ||
| JPWO2023008461A5 (enExample) | ||
| CA3160526A1 (en) | Pharmaceutical combination and use thereof | |
| RU2025104409A (ru) | Лекарственное средство для лечения и/или предупреждения злокачественной опухоли | |
| RU2025104410A (ru) | Лекарственное средство для лечения и/или предупреждения злокачественной опухоли | |
| RU2025104333A (ru) | Лекарственное средство для лечения и/или предупреждения злокачественной опухоли |